Artículos del autor

solaci

Day 2

PROTECT: A comparison of thrombosis incidence between the drug-eluting stents sirolimus and zotarolimus.

Summary: Randomized, open, pragmatic essay PROTECT (patient related outcomes of Endeavor versus Cypher stenting trial) compared two...
solaci -
Day 2

IABP-SHOCK II: Intra-aortic balloon use impact on 30-day mortality in patients with cardiogenic shock.

 IABP-SHOCK II: Intra-aortic balloon use impact on 30-day mortality in patients with cardiogenic shock. Holger Thiele2012-08-26Original title: IABP-SHOCK II:...
solaci -
Day 2

FAST MI: AMI improved the survival associated with the clinical characteristics changes of patients in the French National Registry.

Presentation Summary: The French National Registry included patients admitted with acute myocardial infarction between 1995 and 2010...
solaci -
Day 2

GARY: German Aortic Valve Registry.

Presentation Summary: The German Aortic Stenosis Registry collected data from German centers. 13,860 patients who were undergoing...
solaci -
Day 2

GRACE: Use of insulin glargine and fatty acids to reduce atherosclerosis progression.

Presentation Summary: There is a clear association between hyperglycemia and the development of atherosclerosis. The GRACE sub...
solaci -
Day 2

ACCESS-EUROPE: 12 months results in percutaneous treatment of mitral insufficiency .

Presentation Summary: ACCESS-EUROPE multicenter registry included 567 patients with severe mitral regurgitation treated with Mitral Clip in...
solaci -
Day 3

FAME II: Ischemia guided (IG) percutaneous coronary intervention (PCI) is superior to medical treatment.

Review: Stable coronary disease remains a scenario where percutaneous coronary intervention, (PCI), has not cleared the edges....
solaci -
Day 3

XIMA: Randomized prospective study comparing everolimus eluting stents versus conventional stent implantation in octogenarians.

Background: Octogenarian patients represent an increasingly growing population. In addition, this age group has a higher proportion...
solaci -